QA: Viking Therapeutics Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001607678_2018_Viking_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001607678')"}

Graph

Absolute values for 0001607678, Viking Therapeutics Inc.

  xvar xval
0 AssetsCurrent 21,851,798
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 269,613
4 LiabilitiesCurrent 8,656,575
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,329,003
9 ResearchAndDevelopmentExpense 13,741,186
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,507,476
13 remainder_ComprehensiveNetIncome -12,877
  yvar yval
0 Assets 22,121,411
1 Liabilities 8,656,575
2 Expenses 19,070,189
3 Revenues 0
4 StockholdersEquity 13,464,836
5 NetIncome -20,577,665
6 ComprehensiveNetIncome -20,584,104
7 BaseVar 25,684,264
8 EconomicCapitalRatio 0.167

Edgar->Model Mapping

Feature Distribution

Change over Time